Main Street Capital's Solcher Acquires More Shares via DRIP
Stephen B. Solcher of Main Street Capital Corp increases his stake in the company through a dividend reinvestment plan, reflecting confidence in future performance.
Lane Brian E. reports stock transactions in Main Street Capital
Brian E. Lane reports multiple stock transactions in Main Street Capital Corp, reflecting ongoing investment through a dividend reinvestment plan.
Main Street Capital reports director stock transactions
Main Street Capital Corp discloses stock transactions by director Dunia A. Shive, reflecting ongoing investment activities and market confidence.
Harrington Robert Arthur acquires 195 shares of Cytokinetics
Harrington Robert Arthur increases his stake in Cytokinetics by acquiring 195 shares, reflecting confidence in the pharmaceutical sector.
Gottwald reports stock sale, reduces holdings in Tredegar Corp
William M. Gottwald has reported a significant stock sale, reducing his holdings in Tredegar Corp, which could impact investor perceptions.
Cytokinetics director Daly James M acquires 195 shares
Daly James M of Cytokinetics Inc acquired 195 shares of common stock, reflecting executive confidence in the company's future.
Gottwald reports major stock transaction in Tredegar Corp
James T. Gottwald discloses significant stock transactions involving Tredegar Corp, indicating shifts in ownership within the manufacturing sector.
Wendell Wierenga acquires shares in Cytokinetics Inc.
Wendell Wierenga, director at Cytokinetics, acquires 97 shares, signaling confidence in the company amidst ongoing industry developments.
CEO Gerteisen Increases Stake in Nova Minerals Corp
CEO Gerteisen Christopher boosts his stake in Nova Minerals Corp with recent stock purchases, signaling confidence in the company's future.
Dempsey James G. acquires over 65,000 shares in Frontier Group
Dempsey James G. reports acquisition of over 65,000 shares in Frontier Group Holdings, signaling ongoing confidence in the air transportation sector.
Mineralys Therapeutics reports director stock transactions
Mineralys Therapeutics, Inc. discloses stock transactions by director Kristine Peterson, indicating continued investment and confidence in the company.
CFO Mitchell Mark Christopher Reports Stock Transactions
CFO Mitchell Mark Christopher discloses stock transactions involving Frontier Group Holdings, revealing key financial maneuvers in the airline industry.
KKR Private Equity Conglomerate grants stock award to board member
KKR Private Equity Conglomerate LLC awarded stock to board member Kelly Marie Williams, reflecting its commitment to leadership incentives in the finance services sector.
Tillman's Corner Trust Sells 2.4 Million Shares of Falcon's Beyond
Tillman's Corner Trust has sold 2.4 million shares of Falcon's Beyond Global, marking a significant reduction in its ownership stake.
Elanco CFO VanHimbergen Acquires Deferred Stock Units
Elanco Animal Health CFO Robert M. VanHimbergen acquires deferred stock units, reflecting ongoing executive compensation strategies in the pharmaceutical sector.
Wang Yanjun Reports Share Sales Under Trading Plan
Wang Yanjun, CCO and General Counsel of Sea Ltd, reports multiple share sales under a trading plan, reflecting strategic financial management.
Gottwald reports significant Tredegar stock transaction
John D. Gottwald discloses a major stock transaction involving Tredegar Corp, reflecting changes in ownership dynamics in the manufacturing sector.
ADAR1 Capital Management Increases Stake in InMed Pharmaceuticals
ADAR1 Capital Management has reported increased stock holdings in InMed Pharmaceuticals, reflecting ongoing investment in the pharmaceutical sector.
Cytokinetics EVP Malik Ibraham Executes Stock Transactions
Malik Fady Ibraham of Cytokinetics acquires and sells shares, reflecting active management of his stock holdings in the pharmaceutical company.
Oil-Dri CEO Sells 27,125 Shares of Class B Stock
Daniel Jaffee, CEO of Oil-Dri Corp, sells 27,125 shares of Class B stock, reflecting active management of his equity holdings.